Percutaneous absorption: A multiple pathway model

Journal of Controlled Release

Volumn 45, Issue 2, 1997, Pages 141-151

  Lee, Antony J ^a   King, John R ^b   Barret, David A ^b  

^a QuantiSci   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Diffusion; Mathematical modelling; Percutaneous absorption

Indexed keywords

ARTICLE; DIFFUSION; DRUG PENETRATION; MATHEMATICAL MODEL; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; THEORETICAL STUDY;

EID: 0031049220     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01567-2     Document Type: Article

References (29)

1. R.O. Potts, D.B. Bommannan and R.H. Guy, Percutaneous absorption. In: H. Mukhtar (Ed.), Pharmacology of the Skin, CRC Press, Boca Raton, 1992, pp. 14-27.
2. R.J. Scheuplein, Permeability of the skin: a review of major concepts and some new developments. J. Invest. Dermatol. 67 (1976) 672.
3. W.J. Addicks, G. Flynn, N. Weiner and R. Curl, A mathematical model to describe drug release from thin topical applications. Int. J. Pharm. 56 (1989) 243-248.
4. J. Hadgraft, The epidermal reservoir: a theoretical approach. Int. J. Pharm. 2 (1979) 265-274.
5. K. Kubota and T. Ishizaki, A theoretical consideration of percutaneous drug absorption. J. Pharmacokinet. Biopharmacol. 13 (1985) 55-73.
6. K. Kubota and T. Ishizaki, A calculation of percutaneous drug absorption. I. Theoretical. Comp. Biol. Med. 16 (1986) 7-19.
7. K. Tojo, Concentration profile in plasma after transdermal drug delivery. Int. J. Pharm. 43 (1988) 201-205.
8. F. Yamashita, Y. Koyama, H. Sezaki and M. Hashida, Estimation of a concentration profile of acyclovir in the skin after topical administration. Int. J. Pharm. 89 (1993) 199-206.
9. R.H. Guy, J. Hadgraft and H.I. Maibach, A pharmacokinetic model for percutaneous absorption. Int. J. Pharm. 11 (1982) 119-129.
10. K.H. Valia, K. Tojo and Y.W. Chien, Long term permeation kinetics of estradiol. III. Kinetic analyses of the simultaneous skin permeation and bioconversion of estradiol esters. Drug. Dev. Ind. Pharm. 11 (1985) 1133-1173.
11. C.D. Yu, J.L. Fox, N.F.H. Ho and W.I. Higuchi, Physical model evaluation of topical prodrug delivery - simultaneous transport and bioconversion of vidarabine-5′-valerate. II. Parameter determination. J. Pharm. Sci. 68 (1979) 1347-1357.
12. G. Ackermann and G.L. Flynn, Ether water partitioning and permeability through nude-mouse skin in vitro. 1. Urea, thiourea, glycerol and glucose. Int. J. Pharm. 36 (1987) 61-66.
13. G. Ackermann, G.L. Flynn and W.M. Smith, Ether water partitioning and permeability through nude-mouse skin in vitro. 2. Hydrocortisone 21-normal-alkyl esters, alkanols and hydrophilic compounds. Int. J. Pharm. 36 (1987) 67-71.
14. C.R. Behl, G.L. Flynn, T. Kurihara, W.M. Smith, N.H. Bellantone, O. Gatmaitan, W.I. Higuchi, N.F.H. Ho and C.L. Pierson, Age and anatomical site influences on alkanol permeation of skin of the male hairless mouse. J. Soc. Cosmet. Chem. 35 (1984) 237-252.
15. R.J. Scheuplein and I.H. Blank, Permeability of the skin. Physiol. Rev. 51 (1971) 702.
16. T. Hatanaka, M. Inuma, K. Sugibayashi and Y. Morimoto, Prediction of skin permeability of drags. 2. Development of composite membrane as a skin alternative. Int. J. Pharm. 79 (1992) 21-28.
17. F. Yamashita, T. Yoshioka, Y. Koyama, H. Okamoto, H. Sezald and M. Hashida, Analysis of skin penetration enhancement based on a two layer diffusion model with polar and nonpolar routes in the stratum corneum: dose-dependent effect of 1-geranylazacycloheptan-2-one on drugs with different lipophilicities. Biol. Pharm. Bull. 16 (1993) 690-697.
18. M. Heisig, R. Lieckfeldt, G. Wittum, G. Mazurkevich and G. Lee, Non-steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model. Pharm. Res. 13 (1996) 421-426.
19. D. Bommannan, R.O. Potts and R.H. Guy, Examination of stratum corneum barrier function in vivo by infrared spectroscopy. J. Invest. Dermatol. 95 (1990) 403-408.
20. J. Kao, The influence of metabolism on percutaneous absorption. In: R.I. Bronaugh and H.I. Maibach (Eds.), Percutaneous Absorption, Marcel Dekker, New York, 1989, pp. 259-282.
21. R.H. Guy and J. Hadgraft, Percutaneous metabolism with saturable enzyme kinetics. Int. J. Pharm. 11 (1982) 187-197.
22. K. Tojo, Mathematical modelling of transdermal drug delivery. J. Chem. Eng. Jpn. 20 (1987) 300-308.
23. T.R. Auton, Concentration-flux relations for a multicellular biological membrane with metabolism. Math. Biosci. 115 (1993) 103-117.
24. A.J. Lee, J.R. King and T.G. Rogers, A multiple pathway model for the diffusion of drugs in skin. IMA J. Math. Appl. Med. Biol. 13 (1996) 127-150.
25. A.J. Lee, PhD Thesis, Department of Theoretical Mechanics, University of Nottingham, 1996.
26. R. Lange-Lieckfeldt and G. Lee, Use of a model lipid matrix to demonstrate the dependence of the stratum corneum's barrier properties on its internal geometry. J. Control. Release 20 (1992) 183-194.
27. R. Lieckfeldt and G. Lee, Measuring the diffusional path-length and area within membranes of excised human stratum corneum. J. Pharm. Pharmacol. 47 (1995) 26-29.
28. J. Hadgraft, Theoretical aspects of metabolism in the epidermis. Int. J. Pharm. 4 (1980) 229-239.
29. R.J. Scheuplein, Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of penetration. J. Invest. Dermatol. 48 (1967) 79-88.